169 related articles for article (PubMed ID: 21788135)
61. Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors.
Decker M; Si YG; Knapp BI; Bidlack JM; Neumeyer JL
J Med Chem; 2010 Jan; 53(1):402-18. PubMed ID: 19928862
[TBL] [Abstract][Full Text] [Related]
62. Pyrrolo- and pyridomorphinans: non-selective opioid antagonists and delta opioid agonists/mu opioid partial agonists.
Kumar V; Clark MJ; Traynor JR; Lewis JW; Husbands SM
Bioorg Med Chem; 2014 Aug; 22(15):4067-72. PubMed ID: 24973818
[TBL] [Abstract][Full Text] [Related]
63. 2-aminothiazole-derived opioids. Bioisosteric replacement of phenols.
Zhang A; Xiong W; Hilbert JE; DeVita EK; Bidlack JM; Neumeyer JL
J Med Chem; 2004 Apr; 47(8):1886-8. PubMed ID: 15055988
[TBL] [Abstract][Full Text] [Related]
64. Synthesis and evaluation of novel opioid ligands with a C-homomorphinan skeleton.
Ishikawa K; Mochizuki Y; Hirayama S; Nemoto T; Nagai K; Itoh K; Fujii H
Bioorg Med Chem; 2016 May; 24(10):2199-205. PubMed ID: 27079125
[TBL] [Abstract][Full Text] [Related]
65. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies.
Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Nagase H
Bioorg Med Chem Lett; 2012 Apr; 22(8):2689-92. PubMed ID: 22445285
[TBL] [Abstract][Full Text] [Related]
66. Syntheses of 4,6'-epoxymorphinan derivatives and their pharmacologies.
Nemoto T; Fujii H; Narita M; Miyoshi K; Nakamura A; Suzuki T; Nagase H
Bioorg Med Chem; 2008 Apr; 16(8):4304-12. PubMed ID: 18337104
[TBL] [Abstract][Full Text] [Related]
67. Reversal of subtype-selectivity and function by the introduction of a para-benzamidyl substituent to N-cyclopropylmethyl nornepenthone.
Kong L; Ning K; Liu X; Lu J; Chen B; Ye R; Li Z; Jiang S; Tang S; Chai JR; Fang Y; Lan Y; Mai X; Xie Q; Liu J; Shao L; Fu W; Wang Y; Li W
Eur J Med Chem; 2023 Oct; 258():115589. PubMed ID: 37413884
[TBL] [Abstract][Full Text] [Related]
68. Synthesis and Structure-Activity Relationships of 5'-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects.
Vekariya RH; Lei W; Ray A; Saini SK; Zhang S; Molnar G; Barlow D; Karlage KL; Bilsky EJ; Houseknecht KL; Largent-Milnes TM; Streicher JM; Ananthan S
J Med Chem; 2020 Jul; 63(14):7663-7694. PubMed ID: 32530286
[TBL] [Abstract][Full Text] [Related]
69. Discovery of Peripheral κ-Opioid Receptor Agonists as Novel Analgesics.
Suzuki S; Sugawara Y; Inada H; Tsuji R; Inoue A; Tanimura R; Shimozono R; Konno M; Ohyama T; Higashi E; Sakai C; Kawai K
Chem Pharm Bull (Tokyo); 2017; 65(11):1085-1088. PubMed ID: 29093296
[TBL] [Abstract][Full Text] [Related]
70. Design, synthesis, and characterization of 6beta-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypes.
Pelotte AL; Smith RM; Ayestas M; Dersch CM; Bilsky EJ; Rothman RB; Deveau AM
Bioorg Med Chem Lett; 2009 May; 19(10):2811-4. PubMed ID: 19364645
[TBL] [Abstract][Full Text] [Related]
71. [6,7]-heterocycle-fused 14-hydroxymorphinan derivatives: design, synthesis, and opioid receptor activity.
Li F; Yin C; Chen J; Liu J; Xie X; Zhang A
ChemMedChem; 2009 Dec; 4(12):2103-10. PubMed ID: 19847845
[TBL] [Abstract][Full Text] [Related]
72. Opioid binding and in vitro profiles of a series of 4-hdroxy-3-methoxyindolomorphinans. Transformation of a delta-selective ligand into a high affinity kappa-selective ligand by introduction of a 5,14-substituted bridge.
Grundt P; Martinez-Bermejo F; Lewis JW; Husbands SM
J Med Chem; 2003 Jul; 46(14):3174-7. PubMed ID: 12825957
[TBL] [Abstract][Full Text] [Related]
73. Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists.
Dumitrascuta M; Ben Haddou T; Guerrieri E; Noha SM; Schläfer L; Schmidhammer H; Spetea M
J Med Chem; 2017 Nov; 60(22):9407-9412. PubMed ID: 29053268
[TBL] [Abstract][Full Text] [Related]
74. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
[TBL] [Abstract][Full Text] [Related]
75. Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptor.
Sally EJ; Xu H; Dersch CM; Hsin LW; Chang LT; Prisinzano TE; Simpson DS; Giuvelis D; Rice KC; Jacobson AE; Cheng K; Bilsky EJ; Rothman RB
Synapse; 2010 Apr; 64(4):280-8. PubMed ID: 19953652
[TBL] [Abstract][Full Text] [Related]
76. Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1.
Takeuchi K; Holloway WG; McKinzie JH; Suter TM; Statnick MA; Surface PL; Emmerson PJ; Thomas EM; Siegel MG; Matt JE; Wolfe CN; Mitch CH
Bioorg Med Chem Lett; 2007 Oct; 17(19):5349-52. PubMed ID: 17720493
[TBL] [Abstract][Full Text] [Related]
77. Probes for narcotic receptor mediated phenomena. 43. Synthesis of the ortho-a and para-a, and improved synthesis and optical resolution of the ortho-b and para-b oxide-bridged phenylmorphans: compounds with moderate to low opioid-receptor affinity.
Li F; Folk JE; Cheng K; Kurimura M; Deck JA; Deschamps JR; Rothman RB; Dersch CM; Jacobson AE; Rice KC
Bioorg Med Chem; 2011 Jul; 19(14):4330-7. PubMed ID: 21684752
[TBL] [Abstract][Full Text] [Related]
78. Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists.
Noha SM; Schmidhammer H; Spetea M
ACS Chem Neurosci; 2017 Jun; 8(6):1327-1337. PubMed ID: 28125215
[TBL] [Abstract][Full Text] [Related]
79. Novel 6β-acylaminomorphinans with analgesic activity.
Váradi A; Hosztafi S; Le Rouzic V; Tóth G; Urai Á; Noszál B; Pasternak GW; Grinnell SG; Majumdar S
Eur J Med Chem; 2013 Nov; 69():786-9. PubMed ID: 24103580
[TBL] [Abstract][Full Text] [Related]
80. Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor.
Ben Haddou T; Malfacini D; Calo G; Aceto MD; Harris LS; Traynor JR; Coop A; Schmidhammer H; Spetea M
Mol Pain; 2014 Jul; 10():48. PubMed ID: 25059282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]